C278F mutation in FGFR2 gene causes two different types of syndromic craniosynostosis in two Chinese patients

Mol Med Rep. 2017 Oct;16(4):5333-5337. doi: 10.3892/mmr.2017.7248. Epub 2017 Aug 14.

Abstract

The current study was performed with aim to investigate the fibroblast growth factor receptor 2 (FGFR2) gene in two Chinese families with two different forms of syndromic craniosynostosis, and to characterize their associated clinical features. Two families underwent complete ophthalmic examinations, and two patients from each family were diagnosed with craniosynostosis. Genomic DNA was extracted from leukocytes of peripheral blood collected from these two families and from 200 unrelated subjects within the same population as controls. Exons 8 and 10 of the FGFR2 gene were amplified by polymerase chain reaction and directly sequenced. Ophthalmic examinations of the two patients revealed shallow orbits and ocular proptosis, accompanied by midface hypoplasia and craniosynostosis. Case 1 had retinal detachment, abnormal limbs and hands, while case 2 exhibited normal hands and feet upon clinical examination. A heterozygous FGFR2 missense mutation c.833G>T (C278F) in exon 8 was identified in these two patients, but not in unaffected family members or the normal controls. Although FGFR2 gene mutations and polymorphisms have been studied in various ethnic groups, we report a mutation of FGFR2 in two different Chinese patients with two different types of syndromic craniosynostosis.

Publication types

  • Case Reports

MeSH terms

  • Alleles*
  • Amino Acid Substitution*
  • Child
  • Codon
  • Craniosynostoses / diagnosis*
  • Craniosynostoses / genetics*
  • DNA Mutational Analysis
  • Exons
  • Facies
  • Female
  • Genetic Association Studies*
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Mutation*
  • Phenotype
  • Radiography
  • Receptor, Fibroblast Growth Factor, Type 2 / genetics*
  • Syndrome
  • Tomography, X-Ray Computed

Substances

  • Codon
  • Receptor, Fibroblast Growth Factor, Type 2